SNYR Stock Analysis: Buy, Sell, or Hold?

SNYR - Synergy CHC Corp. Common Stock

MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
$0.10
0.00 (3.57%) β–²
5d: -32.54%
30d: -38.71%
90d: -59.02%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 27, 2026 2d

Get Alerted When SNYR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SNYR is down 32.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
See Forward Earnings Fair Value & Price Prediction β†’

In-depth Analysis How we analyze

Valuation Analysis: SNYR is currently trading at $0.10, which is considered oversold relative to its 30-day fair value range of $0.13 to $0.19. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.7) compared to its historical average (3.1). Remarkably, the market is currently pricing in an annual earnings decline of 39.0% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, SNYR is in a downtrend. Immediate support is located at $0.09, while resistance sits at $0.18. The stock is showing strong short-term momentum, up 3.6% recently.

Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $3.75 (+3488.5%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $0.13 - $0.19
Company Quality Score 52/100 (HOLD)
Volume Confirmation MODERATE
Confidence Score 79.5%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (58/100)
  • BULLISH: Strong upward momentum (+3.6%)
  • BULLISH: Trading 3488.5% below Wall St target ($3.75)
  • WARNING: Composite score 52/100 in the bottom quintile β€” this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $0.13 - $0.19
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $0.09
Resistance Level $0.18
Current Trend Downtrend
Technical data as of Aug 24, 2026

Fundamental Context

Forward P/E (Next Year Est.) 0.70
Wall Street Target $3.75 (+3488.5%)
Revenue Growth (YoY) -32.8%
Earnings Growth (YoY) -90.6%
Profit Margin -57.0%
Valuation Discount vs History -39.0% cheaper
PE vs Historical 0.7 vs 3.1 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -39.0% (market-implied from PE analysis)
1-Year Target $0.09 (-10%)
2-Year Target $0.08 (-19%)
3-Year Target $0.08 (-27%)
3-Yr Target (if PE normalizes) (PE: 1β†’3) $0.34 (+224%)
πŸ’‘ Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.7 to 3.1
Stabilization Target: $0.46 (+345.0%)
PE Expansion Potential: +345.0%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 24, 2026 5:43 PM ET
Data refreshes hourly during market hours. Next update: 6:43 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for SNYR.

Create Free Account

Already have an account? Log In

Top Rated Medical Distribution Stocks

Top-rated stocks in Medical Distribution by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
MCK
McKesson Corporation
STRONG BUY
17 analysts
$987 58 HOLD
COR
Cencora Inc.
STRONG BUY
14 analysts
$369 54 HOLD
CAH
Cardinal Health Inc
BUY
17 analysts
$271 51 HOLD
HSIC
Henry Schein Inc
HOLD
16 analysts
$98 40 SELL
QIPT
Quipt Home Medical Corp
STRONG BUY
5 analysts
$4 52 HOLD

More Analysis for SNYR

SNYR Technical Chart SNYR Price Prediction SNYR Earnings Date SNYR Investment Advisor SNYR Fair Price Analyzer SNYR Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals